C9H11NO4
197.19 g/mol
Principio activo (API)Peligro
Levodopa
CAS59-92-7EC200-445-2
Categoría
Principio activo (API)
Clase de Compuesto
Producto natural
Uso Principal
Materia prima farmacéutica
Levodopa is a dopaminergic compound used as an active pharmaceutical ingredient in medications for Parkinson's disease and related conditions. It is typically formulated with a peripheral decarboxylase inhibitor to enhance its effectiveness.
Active pharmaceutical ingredient for Parkinson's disease medicationsComponent in formulations for dopamine-responsive dystoniaIngredient in preparations for restless legs syndrome
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 59-92-7
Compuestos relacionados
SimilarEstructura similarSimilitud 0.73
3-Bromo-L-tyrosine
CAS38739-13-8
n.a
ReferenciaMisma categoría
Tolazoline hydrochloride
CAS59-97-2
active pharmaceutical ingredient
ReferenciaMisma categoría
Bethanechol chloride
CAS590-63-6
muscarinic agonist for urinary retention
ReferenciaMisma categoría
Sulpyrine
CAS5907-38-0
active pharmaceutical ingredient
ReferenciaMisma categoría
Atropine sulfate monohydrate
CAS5908-99-6
active pharmaceutical ingredient
Referencia de Seguridad
Peligro
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H411Toxic to aquatic life with long lasting effects
H412Harmful to aquatic life with long lasting effects
Identificadores
Nombre IUPAC
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
InChIKey
WTDRDQBEARUVNC-LURJTMIESA-N
SMILES
C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
Sinónimos (128)
- L-3
- V-1512
- Levodopa (JP15/USP)
- Levodopa (JP18/USP/INN)
- Levodopa, British Pharmacopoeia (BP)
- Levodopa, European Pharmacopoeia (EP)
- Levodopa, United States Pharmacopeia (USP)
- Levodopum [INN-Latin]
- (-)-Dopa
- 3,4-Dihydroxyphenyl-L-alanine
- 3,4-Dihydroxyphenylalanine
- 3,4-dihydroxy-L-phenylalanine
- 3-Hydroxy-L-tyrosine
- 4-dihydroxyphenylalanine
- Alanine,4-dihydroxyphenyl)-
- Atamet
- Bendopa
- Biodopa
- Brocadopa
- CARBILEV COMPONENT LEVODOPA
- CORBILTA COMPONENT LEVODOPA
- CREXONT COMPONENT LEVODOPA
- Cerepap
- Cidandopa
- DHIVY COMPONENT LEVODOPA
- DOPA, L-
- DOPASNAP COMPONENT LEVODOPA
- DUOPA COMPONENT LEVODOPA
- Deadopa
- Dihydroxy-L-phenylalanine
- Dopaflex
- Dopaidan
- Dopal-fher
- Dopalina
- Dopar
- Dopar (TN)
- Doparkine
- Doparl
- Dopasol
- Dopaston
- Dopaston SE
- Dopastone
- Dopastral
- Dopicar
- Doprin
- Eldopal
- Eldopar
- Eldopatec
- Eurodopa
- Helfo-Dopa
- IPX203 COMPONENT LEVODOPA
- Inbrija
- Insulamina
- L DOPA 4X
- L-3,4-Dihydrophenylalanine
- L-3,4-Dihydroxyphenylalanine
- L-3-Hydroxytyrosine
- L-4-5-Dihydroxyphenylalanine
- L-DOPA (Standard)
- L-DOPA; Levodopa
- L-Dihydroxyphenylalanine
- L-Dopa 1514
- L-Dopa Phenolic
- L-O-Dihydroxyphenylalanine
- L-Tyrosine, 3-hydroxy-
- L-dopa
- L-o-Hydroxytyrosine
- LEVODOPA COMPONENT OF PARCOPA
- LEVODOPA COMPONENT OF SINEMET
- LEVODOPA [MART.]
- Laradopa
- Larodopa
- Ledopa
- Levedopa
- Levodopa (Sinemet)
- Levodopa CRS
- Levodopa RS
- Levodopum
- Levopa
- Madopa (Salt/Mix)
- Maipedopa
- PARCOPA COMPONENT LEVODOPA
- Parcopa
- Parda
- Pardopa
- Phenylalanine, 3,4-dihydroxy-
- Prodopa
- Prolopa
- RYTARY COMPONENT LEVODOPA
- Ro 4-6316
- STALEVO COMPONENT LEVODOPA
- Sinemet
- Sobiodopa
- Syndopa
- Veldopa
- Weldopa
- component of Sinemet
- levodopa